Join to View Full Profile
1400 S Orange AveOrlando, FL 32806
Phone+1 407-648-3800
Fax+1 407-425-5203
Dr. Avgeropoulos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Massachusetts General HospitalFellowship, Neuro-Oncology, 1997 - 1999
Yale-New Haven Medical CenterFellowship, Neuropathology, 1996 - 1997
Medical University of South CarolinaResidency, Neurology, 1992 - 1996
Spartanburg Medical CenterInternship, Transitional Year, 1991 - 1992- Medical University of South CarolinaClass of 1991
Certifications & Licensure
FL State Medical License 1999 - 2026
NC State Medical License 2000 - 2004
CT State Medical License 1996 - 1997
SC State Medical License 1992 - 1996
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Start of enrollment: 2009 Jun 01
- A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma Start of enrollment: 2011 Dec 01
- Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM) Start of enrollment: 2017 Sep 21
- Join now to see all
Publications & Presentations
PubMed
- Electronic Health Record-Enabled Identification and Targeted Multipronged Intervention to Reduce Readmission and Length of Stay Among Patients With Metastatic Cancer.Michelle M Chin, Andrew D Nguyen, Ashlie Jones, Allison Steyl, Patricia I Geddie
JCO Oncology Practice. 2025-06-09 - 3 citationsVirtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors.James L Rogers, Thomas Wall, Alvina A Acquaye-Mallory, Lisa Boris, Yeonju Kim
Journal of Neuro-Oncology. 2024-04-01 - Exceptional and Sustained Response to Belzutifan in Von Hippel-Lindau Disease-Associated Central Nervous System Hemangioblastoma.Mousa Thalji, Vamshi Vadlapatla, Nicholas G Avgeropoulos, Naren Ramakrishna, Said Baidas
Cureus. 2024-01-01
Press Mentions
The University of Florida Investigator Leads Presentation of Immunomic Therapeutics Clinical DataNovember 23rd, 2019
Ground Rounds January 2012December 29th, 2011
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
